Donald M. Arnold, MDCM, MSc, FRCP(C)
Department of Medicine, McMaster University.
Director of the McMaster Centre for Transfusion Research
Dr. Donald Arnold is Associate Professor in the Department of Medicine at McMaster University. He is the Director of the McMaster Centre for Transfusion Research, and holds the John G. Kelton Chair in Translational Research. Dr. Arnold’s research interests are in immune-mediated hematological diseases and the optimal utilization of blood products for transfusion. He is the lead investigator on several multicentre clinical trials in immune thrombocytopenia (ITP) and has developed a translational research program in platelet disorders funded by the Canadian Institutes of Health Research and Canadian Blood Services.
Rachael Grace, MD, MMSc
Assistant Professor of Pediatrics
Harvard Medical School
Medical Director, Hematology Clinic & Clinical Research Program
Boston Children’s Hospital
Dr. Rachael Grace is a Pediatric Hematologist at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and an Assistant Professor at Harvard Medical School in Boston, MA. She is the Medical Director of the Hematology Outpatient Clinical Program and the Hematology Clinical Research Program. In 2012, she coordinated the development of the Pediatric Immune Thrombocytopenia (ITP) Consortium of North America (ICON), a group of >45 investigators and sites in North America focused on improving ITP care and is the director of the consortium’s data coordinating center. She is an investigator on several multicenter clinical research studies in ITP in children. In addition to immune cytopenias, Dr. Grace’s research is also focused on rare hemolytic anemias.
Cyrus Hsia, HBSc, MD, FRCPC
Associate Professor of Medicine,
Schulich School of Medicine & Dentistry
Dr. Cyrus Hsia is an Associate Professor at the Schulich School of Medicine & Dentistry at Western University in London, Ontario
He completed his undergraduate degrees in Mathematics and Human Biology at the University of Toronto, Medical School, Dr. Hsia’s residency was in Internal Medicine and his fellowship training was in Hematology, both at Western University in Ontario (Schulich School of Medicine & Dentistry). Dr. Hsia’s clinical and research areas of interest include laboratory and benign Hematology including ITP, iron deficiency and overload as well as malignant Hematology including myelodysplastic syndromes and myeloproliferative neoplasms.
Matthew Kang, MD, FRCPC
Hematologist, Joseph Brant Hospital
Associate Clinical Professor (Adjunct)
Department of Medicine, McMaster University
Dr. Matthew Kang is an Associate Clinical Professor (Adjunct) in the Department of Medicine at McMaster University in Hamilton, Ontario. He obtained both his Bachelor’s of Health Sciences and his medical degree at McMaster University. He then completed his residency in Internal Medicine and Hematology fellowship at Western University in London Ontario. He currently works as a community hematologist at Joseph Brant Hospital in Burlington, Ontario seeing patient with both benign and malignant disorders. He has a particular clinical interest in benign hematology including ITP and malignant hematology including lymphoma and multiple myeloma.
President and CEO
Platelet Disorder Support Association (PDSA)
Caroline Kruse is President and CEO of the Platelet Disorder Support Association (PDSA), the global leader in empowering patients with Immune Thrombocytopenia (ITP) and other platelet disorders through education, advocacy, research and support.
Caroline’s focus on mission has resulted in developing PDSA’s local ITP support groups to 47 across the U.S. and Canada, creating more programs for children, teens and families affected by ITP, education and awareness initiatives to improve the quality of life for those living with ITP including the National walk/run “Pump it up for Platelets,” and designation of September as National ITP Awareness Month. In 2016, Caroline founded the International ITP Alliance and website globalitp.org, which has expanded to 32 patient associations from 27 countries.
In 2019, PDSA was honored with the Abbey S. Myers Leadership Award by the National Organization for Rare Disorders (NORD) for the organization’s emphasis on research through the establishment of the ITP Natural History Study Registry and ITP Patient-Centered Research Program.
Caroline brings a personal perspective to PDSA as a patient with two rare diseases, including ITP, so she knows firsthand the physical and emotional struggles ITP patients face daily.
David J. Kuter, MD, DPhil
Professor, Medicine, Harvard Medical School
Director, Clinical Hematology, Massachusetts General Hospital
1971 A.B. Harvard College, Cambridge, Massachusetts
1976 D. Phil. Magdalen College, Oxford University, Oxford, England (Biochemistry)
1978 M.D. Harvard Medical School, Boston, Massachusetts
Internship and Residency:
1978-1979 Intern, Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts
1979-1980 Assistant Resident, Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts
1980-1981 Senior Resident, Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts
1983 Chief Resident, Internal Medicine, Massachusetts General Hospital,Boston, Massachusetts
Clinical and Research Fellowships:
1978-1981 Clinical Fellow in Medicine, Harvard Medical School, Boston, Massachusetts
1981-1983 Research Fellow in Medicine, Harvard Medical School, Boston, Massachusetts
1981-1984 Fellow, Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts
1984-1994 Visiting Scientist and Post-doctoral Fellow,
Department of Biology, Massachusetts Institute of Technology, Cambridge, MA
1975-1978 Teaching Fellow, Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts
1983-1991 Instructor in Medicine, Harvard Medical School, Boston, Massachusetts
1984-1994 Visiting Scientist, Department of Biology, Whitaker College, Massachusetts Institute of Technology, Cambridge, Massachusetts
1991-2001 Assistant Professor of Medicine, Harvard Medical School, Boston, Massachusetts
1991-2009 Member of the Affiliated Faculty of the Harvard-MIT Division of Health Sciences and Technology
2001-2008 Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts
2008- Professor or Medicine, Harvard Medical School, Boston, Massachusetts
Hospital or Affiliated Institution Appointments:
1981-1983 Clinical and Research Fellow in Medicine, Massachusetts General Hospital, Boston, Massachusetts
1983-1984 Chief Resident in Medicine, Massachusetts General Hospital, Boston, Massachusetts
1984-1988 Assistant in Medicine, Massachusetts General Hospital, Boston, Massachusetts
1988-1993 Assistant Physician, Massachusetts General Hospital, Boston, Massachusetts
1993-1998 Associate Physician, Massachusetts General Hospital, Boston, Massachusetts
1995- Director of Clinical Hematology, Massachusetts General Hospital, Boston, Massachusetts
1998- Physician, Massachusetts General Hospital, Boston, Massachusetts
Major Administrative Responsibilities:
1995- Director of Clinical Hematology, Massachusetts General Hospital, Boston, Massachusetts
2000- Director Partner’s Clinical Hematology Program, MGH- BWH-DFCI, Boston, Massachusetts
Wendy Lam, B Sc(Pharm), MD, FRCP(C)
Hematologist / Medical Oncologist
Burnaby Hospital Regional Cancer Centre
Director of BC Community Oncology Trialists
Dr. Wendy Lam is a hematologist and medical oncologist at the Burnaby Hospital Regional Cancer Centre.
She received her B.Sc(Pharmacy) at Dalhousie University and her MD from University of British Columbia. She then completed her Internal Medicine residency at UBC and Hematology fellowship at McMaster University.
She is the Director of the British Columbia Community Oncology Trialists, which is a collaborative group of oncologists and hematologists involved in clinical research.
Her other interests include education of patients through meeting with patient groups. She has also been instrumental in organizing meetings for continued medical education.
Charles Li, MD FRCPC
Clinical Associate Professor
University of British Columbia
Vancouver General Hospital,
BC Women’s Hospital &
Dr. Charles Li is a Staff Hematologist at Vancouver General Hospital and a Consultant in Hematology at BC Women’s Hospital and BC Cancer. He received his Bachelor of Medical Science and MD degrees at the University of Alberta. After a year of rotating internship in Edmonton, he completed an Internal Medicine residency followed by his Hematology Fellowship at the University of British Columbia.
Dr. Li is interested in education and was the Chair for Hematology and Lymphatics for the University of British Columbia Medical and Dental Curriculum from 1998-2007. He received the UBC Faculty Certificate of Teaching and Learning in Higher Education in 2005 and the Fay R. Dirks Award for excellence in teaching from Vancouver General Hospital in 2010. As a Clinical Associate Professor, he continues to be involved in medical education to this day from the level of students to hematology fellows.
Dr. Li’s interest in Hematology is broad he looks after patients with both malignant and non-malignant conditions. He has a special interest in Myeloproliferative Neoplasms, Myelodysplastic Syndromes, Chronic Lymphocytic Leukemia and Multiple Myeloma and, on the non-malignant side, he focuses on ITP, Venous Thrombosis and Hemolytic Anemias.
Harold Olney, MD, FRCP(C)
Assistant Professor of Medicine
Université de Montréal
Chief Department of Hematology-Transfusion Medicine
Centre Hospitalier de l’Université de Montréal
A native Montrealer, Dr. Olney pursued undergraduate training in immunology at McGill University prior to completing medical school and hematology training at the same institution. He completed his specialty training in medical oncology at the University of Montreal. A short stay in the Maritimes treating hematology-oncology patients at the Moncton Regional Cancer Center was followed by several years in postgraduate training in cancer cytogenetics, the study of chromosomal changes in disease, at the University of Chicago.
Upon completion of his fellowship in Chicago, Dr. Olney assumed an assistant professorship at the University of Montreal at the Centre Hospitalier de l’Université de Montréal (CHUM) based at the Notre-Dame Hospital site. He is now chief of the department of hematology – transfusion medicine and the scientific director of the cancer cytogenetics laboratory as well as an attending hematologist and oncologist. He is also currently coordinator of the outpatient hematology clinics and the site representative for the adult hematology residency training program and the NCIC hematology group.
Dr. Drew Provan
in Autoimmune Haematology
Barts and The London School of Medicine and Dentistry
Drew Provan is Emeritus Reader in Autoimmune Haematology at Barts and The London School of Medicine and Dentistry in London, UK. He studied molecular genetics at Leicester University, UK before completing his medical degree. After junior medical posts in the UK, Dr Provan undertook research at The Dana–Farber Cancer Institute in Boston, USA on an American Travelling Fellowship awarded by the UK’s Medical Research Council. He subsequently became a Consultant Haematologist at Southampton University NHS Trust before assuming his current position. Dr Provan’s research interests include immune thrombocytopenia (ITP), neutropenia and haemolytic anaemia. He established the UK Adult ITP Registry, a clinical and laboratory database of patients with ITP for symptom recording, genetic analysis and remote monitoring, with the hope of establishing the underlying mechanisms leading to autoantibody production and identifying treatment response genes and surrogate markers. Along with international colleagues, Dr Provan published the consensus guidelines for the diagnosis and management of ITP in children and adults. He has written numerous peer-reviewed papers and book chapters, and has authored several medical books including Molecular Hematology, Oxford Handbook of Clinical Haematology, Oxford Handbook of Clinical and Laboratory Investigation, and ABC of Clinical Haematology, in addition to books on iPhone, iPad and Mac computing.
Dr. Michelle Sholzberg MDCM, MSc., FRCPC
Assistant Professor, University of Toronto
Medical Director of Coagulation Laboratory, Specimen Management and CELTIC Connect
Associate Scientist – Li Ka Shing Knowledge Institute
Director of the Hematology-Oncology Clinical Research Group (HOCRG)
St. Michael’s Hospital
Dr. Michelle Sholzberg received her MDCM and residency training in Internal Medicine at McGill University and she completed additional postgraduate training in Hematology at the University of Toronto. She has also completed a research hemostasis fellowship in Toronto. Dr. Sholzberg has a master’s of science from the University of Toronto in Clinical Epidemiology and Health Care Research. She is a clinical hematologist with a focus on bleeding and is the co-director of the Hemophilia Program at St. Michael’s Hospital. She is also the medical director of the Coagulation Laboratory, Specimen Management and CELTIC Connect in the Department of Laboratory Medicine. She is the co-director of the Hematology-Oncology Clinical Research Group and of the Hematology-Immunology Translational Research Theme. Her research interests include inherited and acquired disorders of hemostasis. Currently, she is involved in the study of: prediction tools for perioperative bleeding, quality improvement in care of pregnant women, the appropriateness of coagulation testing and new treatments for immune thrombocytopenia.